LifeSci Capital Sticks to Its Hold Rating for Repare Therapeutics (RPTX)

Like
Comment
Favorite

LifeSci Capital Sticks to Its Hold Rating for Repare Therapeutics (RPTX)

TIPRANKS03-03

LifeSci Capital analyst Charles Zhu maintained a Hold rating on Repare Therapeutics (RPTX – Research Report) today. The company’s shares opened tod...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

7x24

All

04:13
Emirates Islamic Bank Q1 Profit 1.01 Bln Dirhams
04:13
L'Oreal : Jefferies Cuts Target Price to EUR 369 From EUR 374
04:12
Banyan Group Publishes 2024 Sustainability Report
04:08
CBOE Global Markets Inc : JP Morgan Raises Target Price to $187 From $172
04:07
Exelon Corp : Jefferies Raises Target Price to $52 From $47

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2516590296?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-04 01:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516590296","market":"fut","top_or_hot":-1,"title":"LifeSci Capital Sticks to Its Hold Rating for Repare Therapeutics (RPTX)","media":"TIPRANKS","content":"<div>\n<p>LifeSci Capital analyst Charles Zhu maintained a Hold rating on Repare Therapeutics (RPTX – Research Report) today. The company’s shares opened tod...</p>\n\n<a href=\"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-hold-rating-for-repare-therapeutics-rptx?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n","source":"tipranks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LifeSci Capital Sticks to Its Hold Rating for Repare Therapeutics (RPTX)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifeSci Capital Sticks to Its Hold Rating for Repare Therapeutics (RPTX)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-04 01:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-hold-rating-for-repare-therapeutics-rptx?utm_source=itigerup.com&utm_medium=referral><strong>TIPRANKS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>LifeSci Capital analyst Charles Zhu maintained a Hold rating on Repare Therapeutics (RPTX – Research Report) today. The company’s shares opened tod...</p>\n\n<a href=\"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-hold-rating-for-repare-therapeutics-rptx?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-hold-rating-for-repare-therapeutics-rptx?utm_source=itigerup.com&utm_medium=referral","article_id":"2516590296","we_media_id":null,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-hold-rating-for-repare-therapeutics-rptx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2516590296","pubTimestamp":1741023331,"columns":[],"sourceInfo":{"source_id":"tipranks_highlight","name":"Tipranks"},"weMediaInfo":null,"summary":"LifeSci Capital analyst Charles Zhu maintained a Hold rating on Repare Therapeutics (RPTX – Research Report) today. The company’s shares opened tod...","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"LifeSci Capital维持Repare Therapeutics(RPTX)的持有评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RPTX":1},"content_text":"LifeSci Capital analyst Charles Zhu maintained a Hold rating on Repare Therapeutics (RPTX – Research Report) today. The company’s shares opened tod...","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}